BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 15555141)

  • 1. Obsessive compulsive disorder.
    Soomro GM
    Clin Evid; 2003 Dec; (10):1172-87. PubMed ID: 15555141
    [No Abstract]   [Full Text] [Related]  

  • 2. Obsessive compulsive disorder.
    Soomro GM
    Clin Evid; 2004 Jun; (11):1319-34. PubMed ID: 15652061
    [No Abstract]   [Full Text] [Related]  

  • 3. Obsessive compulsive disorder.
    Soomro GM
    Clin Evid; 2005 Dec; (14):1270-83. PubMed ID: 16620454
    [No Abstract]   [Full Text] [Related]  

  • 4. Augmenting obsessive-compulsive disorder treatment: from brain to mind.
    Ressler KJ; Rothbaum BO
    JAMA Psychiatry; 2013 Nov; 70(11):1129-31. PubMed ID: 24026506
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of obsessive-compulsive disorder in an adult].
    Kähkönen S; Holmberg N
    Duodecim; 2010; 126(11):1310-6. PubMed ID: 20681354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation with cognitive behavioural therapy has superior efficacy to augmentation with risperidone for treating adults with treatment-resistant OCD.
    O'Neill J
    Evid Based Ment Health; 2014 May; 17(2):58-9. PubMed ID: 24713316
    [No Abstract]   [Full Text] [Related]  

  • 7. Treating obsessive-compulsive disorder. Options include medication, psychotherapy, surgery, and deep brain stimulation.
    Harv Ment Health Lett; 2009 Mar; 25(9):4-5. PubMed ID: 19368037
    [No Abstract]   [Full Text] [Related]  

  • 8. Managing the patient with treatment-resistant obsessive compulsive disorder: current strategies.
    Jenike MA; Rauch SL
    J Clin Psychiatry; 1994 Mar; 55 Suppl():11-7. PubMed ID: 7915709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating obsessive compulsive disorder.
    Veale D
    Practitioner; 2002 Mar; 246(1632):181, 184-6. PubMed ID: 11901781
    [No Abstract]   [Full Text] [Related]  

  • 10. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
    Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
    JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of compulsive hoarding.
    Saxena S; Maidment KM
    J Clin Psychol; 2004 Nov; 60(11):1143-54. PubMed ID: 15389621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmenting SRIs for Obsessive-Compulsive Disorder: Patient Preference for Risperidone Does Not Limit Effectiveness of Exposure and Ritual Prevention.
    Wheaton MG; Carpenter JK; Kalanthroff E; Foa EB; Simpson HB
    Psychother Psychosom; 2016; 85(5):314-6. PubMed ID: 27513584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obsessive-compulsive disorder (OCD): Practical strategies for pharmacological and somatic treatment in adults.
    Fineberg NA; Reghunandanan S; Simpson HB; Phillips KA; Richter MA; Matthews K; Stein DJ; Sareen J; Brown A; Sookman D;
    Psychiatry Res; 2015 May; 227(1):114-25. PubMed ID: 25681005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current issues in the pharmacologic management of obsessive compulsive disorder.
    Rasmussen SA; Eisen JL; Pato MT
    J Clin Psychiatry; 1993 Jun; 54 Suppl():4-9. PubMed ID: 8101187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obsessive-compulsive disorder in Tourette syndrome.
    Goodman WK; Storch EA; Geffken GR; Murphy TK
    J Child Neurol; 2006 Aug; 21(8):704-14. PubMed ID: 16970872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory obsessive-compulsive disorder: state-of-the-art treatment.
    Hollander E; Bienstock CA; Koran LM; Pallanti S; Marazziti D; Rasmussen SA; Ravizza L; Benkelfat C; Saxena S; Greenberg BD; Sasson Y; Zohar J
    J Clin Psychiatry; 2002; 63 Suppl 6():20-9. PubMed ID: 12027116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The treatment of obsessive-compulsory disorders (compulsory neuroses)].
    Hoogduin CA; Schaap CP
    Ned Tijdschr Geneeskd; 1993 Jun; 137(23):1135-8. PubMed ID: 8316308
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness of cognitive-behavioral therapy addition to pharmacotherapy in resistant obsessive-compulsive disorder: a multicenter study.
    Albert U; Aguglia A; Bogetto F; Cieri L; Daniele M; Maina G; Necci R; Parena A; Salvati L; Tundo A
    Psychother Psychosom; 2012; 81(6):383-5. PubMed ID: 22964775
    [No Abstract]   [Full Text] [Related]  

  • 19. [Resistance and refractoriness in obsessive-compulsive disorder].
    Ferrão YA; Diniz JB; Lopes AC; Shavitt RG; Greenberg B; Miguel E
    Braz J Psychiatry; 2007 Oct; 29 Suppl 2():S66-76. PubMed ID: 18172943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: What moderates improvement?
    Wheaton MG; Rosenfield D; Foa EB; Simpson HB
    J Consult Clin Psychol; 2015 Oct; 83(5):926-937. PubMed ID: 26009783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.